Tootsie Roll CEO dies, wife Ellen Gordon named successor: WSJ
Turkish Republic, Ministry of Health ‘Türkiye Hudut ve Sahiller Genel Müdürlüğü’ to Acquire Advanced Cancer Treatment Systems from Elekta
UPDATE: Here's the No. 1 portfolio fix you should make now
UPDATE: Here's the top portfolio fix you should make now
Research and Markets: Global Distance Measurement Sensors Market 2014-2020 - SICK, Omron, Pepperl+Fuchs, Baumer, Banner Engineering Lead the $2.5 Billion Industry
Our Ultimate Stock-Pickers Index continues to beat the market even as relatively few of our top managers are outperforming the S&P 500.
The continuing U.S. stock market rally has diminished the number and similarity of purchases across these top managers.
DISCLAIMER, Last updated April 21, 2010 SumZero is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice. There is no requirement that any of our Information Providers be registered investment advisors or broker-dealers. Nothing published by SumZero should be considered personalized investment advice, investment services or a solicitation to BUY, SELL, or HOLD any securities mentioned by SumZero or the Information Providers. Never buy stocks based purely on our publication or information, as even past performance is not necessarily indicative of future results. YOU SHOULD VERIFY ALL CLAIMS, DO YOUR OWN DUE DILIGENCE AND/OR SEEK YOUR OWN PROFESSIONAL ADVISOR AND CONSIDER THE INVESTMENT OBJECTIVES AND RISKS BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTMENT DOES NOT GUARANTEE A POSITIVE RETURN AS STOCKS ARE SUBJECT TO MARKET RISKS, INCLUDING THE POTENTIAL LOSS OF PRINCIPAL. You further acknowledge that SumZero, the Information Providers or their respective affiliates, employers, employees, officers, members, managers and directors, may or may not hold positions in one or more of the securities in the Information and may trade at any time, without notification to you, based on the information they are providing and will not necessarily disclose this information to subscribers, nor the time the positions in the securities were acquired. You confirm that you have read and understand, and agree to, our full disclaimer, a copy of which can be accessed by clicking here.
We're setting the record straight on the TR , PR, and NR designations.